Jeffrey B. Ulmer

2 months ago | biopharminternational.com | Chris Spivey |Philip R. Dormitzer |Phil Felgner |Jeffrey B. Ulmer |Andy Geall

The pivotal paper series brings to a wider audience a sharp focus on important advances in the biomedical field. This particular paper comes at a troubling time in the vaccine industry, which is currently beset by misinformation and disinformation.